Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_992_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Contributors
- •Series Editors' preface
- •Editors' preface
- •Acknowledgements
- •Chronic liver failure
- •Metabolic liver function
- •Measuring liver volume
- •Blood tests of liver function
- •Tests of liver function measuring substance clearance
- •Indocyanine green (ICG)
- •Hepatobiliary scintigraphy
- •Lidocaine (MEG-X)
- •Aminopyrine breath test
- •Urea synthesis
- •Glutathione synthesis
- •Measuring liver blood flow
- •Effect of major liver resection on hepatic blood flow
- •Effect of major liver resection on innate immunity
- •Liver regeneration
- •Molecular signals for hepatic regeneration
- •Cell populations involved in liver regeneration
- •Evidence-based practice in surgery
- •Overview of liver functions and evolution
- •Symptoms of liver failure: acute and chronic
- •Common causes of acute liver failure: hepatic insufficiency following liver resections
- •Consequences of surgery
- •Small-for-size syndrome
- •Hepatic steatosis
- •Assessment of steatosis
- •Chemotherapy-induced liver changes
- •Portal vein embolisation
- •Technique
- •Therapy for liver failure
- •N -Acetyl cysteine
- •Nutritional support in liver failure
- •Artificial extracorporeal liver support
- •Artificial liver support
- •Bioartificial liver systems
- •Liver transplantation
- •Cell therapy for liver failure: general principles
- •Haemopoetic stem cell therapy for liver disease in humans
- •Future developments
- •References
- •Liver
- •Overview of hepatic anatomy and terminology
- •Divisions of the liver based on the hepatic artery
- •Resectional terminology
- •Surgical anatomy for liver resections
- •Hepatic arteries and liver resections
- •Bile ducts and liver resections
- •Prevailing pattern and important variations of bile ducts draining the right hemiliver
- •Prevailing pattern and important variations of bile ducts draining the left hemiliver
- •Prevailing pattern of bile ducts draining the caudate lobe (Sg1)
- •Portal veins and liver resections
- •Ramification of the left portal vein (Figs 2.10 and 2.11)
- •Hepatic veins and liver resection (Fig. 2.13)
- •The plate/sheath system of the liver
- •Liver capsule and attachments
- •Surface anatomy
- •Gallbladder and extrahepatic bile ducts
- •Gallbladder
- •Agenesis of the gallbladder
- •Double gallbladder
- •Cystic duct
- •Cystic artery
- •Extrahepatic bile ducts
- •Anomalies of extrahepatic bile ducts
- •Extrahepatic arteries
- •Blood supply of bile ducts
- •Pancreas
- •Pancreatic ducts
- •Blood supply of the pancreas
- •Lymphatics of the pancreas
- •References
- •Introduction
- •Colorectal liver metastases
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Hepatocellular carcinoma
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Pancreatic and periampullary carcinoma
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •Endoscopic ultrasound
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •References
- •Introduction
- •Proximal bile duct tumours
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Endoscopic retrograde cholangiopancreatography
- •Classification
- •Haemangiomas
- •Pathology
- •Clinical presentation
- •Management
- •Liver cell adenoma
- •Pathology
- •Clinical presentation
- •Management
- •Focal nodular hyperplasia
- •Pathology
- •Clinical features
- •Management
- •Nodular regenerative hyperplasia (macroregenerative nodules)
- •Bile duct adenoma (bile duct hamartoma)
- •Hepatic pseudotumours
- •Miscellaneous benign tumours
- •Liver abscess
- •Clinical presentation
- •Management
- •Amoebic abscess
- •Hydatid cyst
- •Clinical presentation
- •Management
- •Simple cysts of the liver
- •Clinical presentation
- •Management
- •Polycystic liver disease (PCLD)
- •Clinical presentation
- •Management
- •Cystadenoma
- •References
- •Introduction
- •Hepatocellular carcinoma
- •Incidence of HCC
- •Risk factors for HCC
- •Cirrhosis
- •HBV infection
- •HCV infection
- •Human immunodeficiency virus (HIV) infection
- •Other viral infections
- •Alcohol
- •Non-alcoholic fatty liver disease (NAFLD)
- •Hereditary haemochromatosis
- •Cirrhosis of other aetiologies
- •Aflatoxin
- •Metabolic liver diseases
- •Adenoma, contraceptives and androgens
- •Pathology of HCC and nodular lesions in chronic liver disease
- •Clinical presentation
- •Liver function tests and tumour markers
- •Liver function tests
- •Serum tumour markers
- •α-Fetoprotein
- •Others serum tumour markers
- •Radiological studies
- •Ultrasound
- •Computed tomography
- •Magnetic resonance imaging
- •Contrast-enhanced ultrasound
- •Other imaging
- •Angiography
- •Positron emission tomography
- •Accuracy of imaging techniques
- •Requirement for and reliability of histological assessment
- •Diagnosis of HCC
- •Natural history of HCC and staging systems
- •Screening for HCC
- •Treatment options
- •HCC in normal livers
- •Liver resection of HCC in cirrhotic patients
- •Liver resection
- •Main limitations
- •Risk of surgery and patient selection
- •Technique
- •Outcome after resection
- •Treatment of recurrence
- •Liver transplantation (LT)
- •Rationale
- •Patient selection
- •Treatment on the waiting list
- •Transarterial chemoembolisation (TACE)
- •Technique
- •Contraindications
- •Morbidity and mortality
- •Monitoring
- •Efficacy
- •Percutaneous local ablative therapy
- •Technique
- •Advantages and drawbacks
- •Contraindications and limitations
- •Methods and margins
- •Indication
- •Other palliative treatments
- •Conventional systemic chemotherapy
- •Anti-angiogenic targeted therapies
- •Radioembolisation
- •Other treatments
- •Defining a treatment strategy
- •Uncomplicated HCC associated with chronic liver disease
- •Treatment of complicated HCC
- •HCC with macroscopic portal vein invasion
- •HCC with macroscopic invasion of hepatic veins
- •Ruptured HCC
- •Fibrolamellar carcinoma (FLC)
- •Intrahepatic cholangiocarcinoma (ICCA)
- •Incidence
- •Risk factors
- •Classification and staging
- •Pathology and progression analysis
- •Clinical presentation and laboratory tests
- •Imaging studies
- •Diagnosis
- •Treatment
- •Angiosarcoma
- •Primary hepatic lymphoma
- •References
- •Introduction
- •Preoperative staging: the key to selection of candidates for curative treatment
- •Computed tomography (CT)
- •Magnetic resonance imaging (MRI)
- •Positron emission tomography (PET)
- •Staging laparoscopy
- •Cardiopulmonary exercise testing
- •Surgery: the old and the new standards for resection
- •Criteria for resection
- •Surgical strategies to improve resectability
- •Portal vein embolisation
- •Two-stage hepatectomy
- •Repeat hepatectomy
- •Extreme liver surgery
- •Extrahepatic colorectal disease
- •Techniques of surgical resection
- •Transection techniques
- •Fibrin sealants
- •Laparoscopic liver surgery: less is more?
- •Morbidity, mortality and survival after liver resection for CRLMs
- •Classification of CRLMs
- •Staging systems and terminology
- •Chemotherapy for CRLMs
- •Agents
- •Clarifying the intent of chemotherapy in CRLMs
- •Conversion/induction chemotherapy
- •Perioperative chemotherapy
- •Pathological response to chemotherapy as a predictor of long-term outcome
- •Chemotherapy-associated hepatotoxicity
- •Liver-targeted therapies
- •Hepatic arterial infusion
- •Drug-eluting beads for TACE (DEB-TACE)
- •Selective internal radiation treatment (SIRT)
- •Ablative therapies for CRLMs
- •Radiofrequency ablation
- •Microwave ablation
- •Multidisciplinary team approach
- •Conclusions
- •References
- •Introduction
- •Pathophysiology and molecular basis of liver metastases
- •Treatment strategies
- •Neuroendocrine tumours
- •Gastrointestinal stromal tumours
- •Breast cancer
- •Ovarian cancer
- •Renal cell carcinoma
- •Melanoma
- •Non-colorectal gastrointestinal adenocarcinoma
- •Testicular cancer
- •Urothelial cancer
- •Lung cancer
- •Adrenocortical tumours
- •Endometrial cancer
- •Conclusion
- •References
- •Introduction
- •Aetiology and pathophysiology of portal hypertension
- •The natural history of portal hypertension
- •Presentation
- •Imaging
- •Management of varices
- •Therapeutic aims for pharmacological therapy in portal hypertension
- •Oesophageal varices
- •Primary prophylaxis for the prevention of variceal haemorrhage
- •Prevention of re-bleeding from oesophageal varices (secondary prophylaxis)
- •Treatment for bleeding oesophageal varices
- •Gastric varices
- •Portal hypertensive gastropathy
- •Second-line therapies
- •TIPS (transjugular intrahepatic portosystemic shunt)
- •TIPS for variceal bleeding
- •Surgical options
- •Portal systemic shunts
- •Liver transplantation
- •Selection of second-line therapy
- •Non-cirrhotic
- •Cirrhotic
- •Management of ascites
- •Budd–Chiari syndrome
- •Acute Budd–Chiari syndrome
- •Chronic Budd–Chiari syndrome
- •Non-cirrhotic portal hypertension
- •Portal vein thrombosis
- •Segmental portal hypertension
- •TIPS and portal vein thrombosis
- •References
- •Introduction
- •Postsplenectomy sepsis
- •Trauma
- •Elective indications for splenectomy
- •Immune thrombocytopenic purpura
- •Evans syndrome
- •Hereditary spherocytosis
- •Elliptocytosis
- •Thallassaemias
- •Sickle cell anaemia
- •Autoimmune haemolytic anaemia
- •Lymphoma
- •Myeloid disease
- •Volvulus
- •Haemangiomas
- •Cysts
- •Portal hypertension
- •Preparation for splenectomy
- •Technique
- •Open splenectomy
- •Laparoscopic splenectomy
- •Postoperative management and complications
- •Summary
- •References
- •Introduction
- •Composition, formation and risk factors
- •Presentation
- •Cholecystolithiasis
- •Pathophysiology
- •Clinical features
- •Choledocholithiasis
- •Pathophysiology
- •Clinical features
- •Investigation
- •Blood tests
- •Ultrasonography
- •Endoscopic ultrasound (EUS)
- •Computed tomography (CT)
- •Radioisotope scanning
- •Magnetic resonance cholangiopancreatography (MRCP)
- •Percutaneous transhepatic cholangiography (PTC)
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •Management of gallbladder stones
- •Asymptomatic stones
- •Non-operative treatments for gallstones
- •Dissolution
- •Lithotripsy
- •Operative treatment of gallbladder stones
- •Open cholecystectomy
- •Mini-laparotomy cholecystectomy
- •Laparoscopic cholecystectomy
- •Symptomatic gallstones
- •Acute cholecystitis
- •Complications
- •Day-case laparoscopic cholecystectomy
- •Needlescopic cholecystectomy
- •Bile duct injury
- •Cholecystostomy
- •Subtotal cholecystectomy
- •Intraoperative cholangiography (IOC)
- •Routine IOC
- •Selective IOC
- •Bile duct injury
- •Laparoscopic ultrasound (LUS)
- •Management of common bile duct stones
- •Laparoscopic transcystic common bile duct exploration
- •Laparoscopic choledochotomy
- •Open choledochotomy
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •ERCP stent insertion
- •Preoperative ERCP
- •Intraoperative ERCP
- •Postoperative ERCP
- •Laparoscopic exploration of the CBD versus preoperative or postoperative ERCP
- •Recurrent or retained CBD stones
- •Transhepatic stone retrieval
- •Acalculous biliary pain
- •References
- •Introduction
- •Congenital anomalies
- •Biliary atresia
- •Choledochal cysts
- •Classification
- •Risk of malignancy
- •Management
- •Special operative techniques
- •Iatrogenic biliary injury
- •Aetiology
- •Techniques to avoid injury
- •Classification
- •Presentation
- •Management
- •Intraoperative recognition
- •Postoperative recognition: biliary fistula
- •Postoperative recognition: biliary obstruction
- •The timing of repair
- •Early repair
- •Delayed repair
- •Associated vascular injury
- •Further imaging
- •Operative techniques
- •Management of complications related to repair
- •Revisional surgery
- •Liver resection and transplantation
- •Prognosis
- •Success of repair
- •Survival
- •Quality of life
- •Associated malignancy
- •Benign biliary strictures
- •Mirizzi's syndrome
- •Presentation
- •Management
- •Hepatolithiasis
- •Management
- •Parasitic infestation causing jaundice
- •Liver flukes (trematodes)
- •Echinococcus
- •Treatment
- •Ascaris lumbricoides
- •Primary sclerosing cholangitis
- •Aetiology
- •Presentation
- •Investigation
- •Management
- •Exclusion of associated malignant stricture
- •Biliary strictures imitating malignancy
- •Lymphoplasmacytic sclerosing pancreatitis
- •Functional biliary disorders
- •References
- •Introduction
- •Cholangiocarcinoma
- •General considerations
- •Epidemiology
- •Natural history
- •Aetiology
- •Histopathology
- •Cholangiocarcinoma involving the proximal bile ducts (hilar cholangiocarcinoma)
- •Clinical presentation and diagnosis
- •Radiological investigation
- •Direct cholangiography
- •Computed tomography
- •Duplex ultrasonography
- •Magnetic resonance cholangiopancreatography (MRCP)
- •Preoperative evaluation and assessment of resectability
- •Treatment options
- •Resection
- •Results of resection
- •Adjuvant therapy
- •Palliation
- •Percutaneous biliary drainage
- •Intrahepatic biliary-enteric bypass
- •Radiation therapy
- •Photodynamic therapy
- •Chemotherapy
- •Cholangiocarcinoma involving the distal bile duct
- •Clinical presentation and diagnosis
- •Staging and assessment of resectability
- •Treatment options
- •Cholangiocarcinoma involving the intrahepatic bile ducts
- •Clinical presentation
- •Diagnosis
- •Radiological investigations
- •Staging and assessment of resectability
- •Treatment options
- •Gallbladder cancer
- •Epidemiology/aetiology
- •Clinical presentation and diagnosis
- •Histopathology and staging
- •Evidence for an aggressive surgical approach
- •Surgical therapy
- •T1 tumours
- •T2 tumours
- •T3 tumours
- •T4 tumours
- •Preoperative suspicion of malignancy
- •Unsuspected malignancy at exploration
- •Malignancy diagnosed post-cholecystectomy
- •Adjuvant therapy
- •Palliation
- •References
- •General description
- •Pathophysiology
- •Natural history
- •Diagnosis
- •Aetiology
- •Obstructive factors
- •Biliary disease
- •Benign pancreatic duct stricture
- •Tumours of the ampulla or pancreas
- •Toxic factors
- •Metabolic factors
- •Genetic defects
- •Trauma
- •Iatrogenic causes
- •Inflammatory
- •Physiological
- •Sphincter manometric abnormalities
- •Assessment of severity
- •Single biochemical measures
- •C-reactive protein (CRP)
- •Other single predictive markers
- •Intra-abdominal hypertension (IAH)
- •Repeated clinical assessment
- •Imaging
- •Role of ultrasound (US)
- •Role of CT
- •Role of magnetic resonance (MR)/magnetic resonance cholangiopancreatography (MRCP)
- •Endoscopic ultrasound (EUS)
- •Management
- •Initial management
- •Supportive management
- •Specific medical management
- •Prevention of infection
- •Nutritional support
- •Nutritional delivery in the patient with acute pancreatitis
- •Disease modulation through content or mode of delivery
- •Other medical therapies
- •Inhibition of pancreatic secretion
- •Inhibition of pancreatic enzymes
- •Inhibition of the inflammatory response
- •Role of ERCP
- •Definitive management issues
- •Prevention of recurrent acute pancreatitis
- •Management of gallstones
- •Investigation of non-gallstone-associated pancreatitis
- •Peripancreatic fluid collections
- •Management of an early fluid collection
- •Management of a pseudocyst
- •Percutaneous drainage
- •Endoscopic drainage
- •Surgical drainage of an acute post-inflammatory collection
- •Management of a pancreatic duct fistula
- •Management of necrosis
- •Management of sterile necrosis
- •Management of infected necrosis (early phase, 2–6 weeks)
- •Methods of necrosectomy
- •Open laparotomy/debridement
- •Minimally invasive approaches to infected necrosis
- •Management of pancreatic abscess
- •Specific late complications
- •Haemorrhage
- •Segmental portal hypertension and gastrointestinal haemorrhage
- •Pancreatic duct stricture
- •Gastric outlet obstruction
- •References
- •Summary
- •Definition
- •Incidence
- •Aetiology
- •Clinical course
- •Pathophysiological findings and pain mechanisms in chronic pancreatitis
- •Calcifying CP
- •Autoimmune pancreatitis
- •Hereditary CP
- •Pathogenesis of pain in chronic pancreatitis
- •Preoperative assessment and investigations
- •Laboratory evaluation
- •Imaging studies
- •Treatment
- •Conservative therapy
- •Endoscopic and interventional treatment
- •Endoscopy
- •Surgical therapy, timing and indications
- •Surgical techniques
- •Selection of the surgical intervention
- •Pancreatico-duodenectomy
- •Distal and total pancreatectomy
- •Partington–Rochelle procedure
- •Longitudinal pancreatico-jejunostomy and cyst drainage
- •Beger procedure
- •Frey procedure
- •Berne procedure
- •Hamburg procedure
- •V-shaped excision
- •Selection of the procedure
- •Salvage procedures
- •Complications of chronic pancreatitis
- •References
- •Introduction
- •Epidemiology
- •Risk factors (see Box 15.1)
- •Smoking
- •Diet and alcohol
- •Occupation
- •Past medical history
- •Hereditary pancreatic cancer
- •Precursor lesions
- •Presentation
- •Investigation
- •Serology
- •Markers
- •Diagnosis
- •Imaging studies
- •Cytology/histology
- •Advanced staging techniques
- •Laparoscopy
- •Pathology
- •Treatment
- •Resection
- •Pancreatico-duodenectomy
- •Extended lymph node and vascular dissection
- •Distal pancreatectomy
- •Laparoscopic pancreatectomy
- •Total pancreatectomy
- •Central pancreatectomy
- •Surgical palliation
- •Obstructive jaundice
- •Upper GI tract outflow obstruction
- •Adjuvant therapies
- •Neoadjuvant therapy
- •Future areas of interest
- •References
- •Introduction
- •Intraductal papillary mucinous neoplasms
- •Clinical presentation
- •Investigation
- •Pathology
- •Management
- •Outcome
- •Pancreatic neuroendocrine tumours
- •Clinical presentation
- •Investigations
- •Biochemical
- •Radiology
- •Treatment
- •Metastatic disease
- •Pathology and outcome
- •Other tumours
- •References
- •Introduction
- •Liver trauma
- •Mechanisms of liver injury
- •Classification of liver injury
- •Diagnosis of liver injury
- •Other diagnostic/therapeutic modalities for the assessment and treatment of liver injury
- •Management of liver injury: selection of patients for non-operative management
- •Operative management of liver injury
- •General strategy
- •Choice of incision
- •Intraoperative assessment
- •Perihepatic packing
- •Techniques for surgical haemostasis
- •Resectional debridement
- •Anatomical liver resection
- •Selective ligation of the hepatic artery
- •Management of hepatic venous and retrohepatic caval injury
- •Ex vivo surgery and liver transplantation
- •Complications of liver trauma
- •Complications of non-operative management
- •Postoperative complications after surgery for liver trauma
- •Outcome after liver injury
- •Extrahepatic biliary tract trauma
- •Incidence of biliary injury
- •Classification of biliary injury
- •Presentation and diagnosis of biliary injury
- •Operative management of biliary injury
- •Outcome after biliary injury
- •Pancreatic trauma
- •Mechanisms of pancreatic injury
- •Diagnosis of pancreatic injury
- •Classification of pancreatic injury
- •Initial management of pancreatic injury
- •Operative management of pancreatic injury
- •Complications of pancreatic injury
- •Conclusion
- •References
- •Index


Hepatobiliary and
Pancreatic Surgery

A COMPANION TO SPECIALIST SURGICAL PRACTICE
Series Editors
O. James Garden
Simon Paterson-Brown
Hepatobiliary and
Pancreatic Surgery
FIFTH EDITION
Edited by
O. James Garden
BSc MBChB MD FRCS(Glas) FRCS(Ed) FRCP(Ed) FRACS(Hon) FRCSC(Hon) FRSE
Regius Professor of Clinical Surgery, Clinical Surgery School of Clinical Sciences,
The University of Edinburgh; Honorary Consultant Surgeon,
Royal Infirmary of Edinburgh, Edinburgh, UK
Rowan W. Parks
MBBCh BAO MD FRCSI FRCS(Ed)
Professor of Surgical Sciences, Clinical Surgery School of Clinical Sciences,
The University of Edinburgh; Honorary Consultant Surgeon,
Royal Infirmary of Edinburgh, Edinburgh, UK
Edinburgh London New York Oxford Philadelphia St Louis Sydney Toronto 2014

Fifth edition © 2014 Elsevier Limited. All rights reserved.
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, recording, or any information storage and retrieval system, without
permission in writing from the publisher. Details on how to seek permission, further information about the
Publisher's permissions policies and our arrangements with organizations such as the Copyright Clearance Center
and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher
(other than as may be noted herein).
First edition 1997
Second edition 2001
Third edition 2005
Fourth edition 2009
Fifth edition 2014
ISBN 978-0-7020-4961-3
e-ISBN 978-0-7020-4969-9
British Library Cataloguing in Publication Data
A catalogue record for this book is available from the British Library
Library of Congress Cataloging in Publication Data
A catalog record for this book is available from the Library of Congress
Notice
Knowledge and best practice in this field are constantly changing. As new research and experience broaden our
understanding, changes in research methods, professional practices, or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds, or experiments described herein. In using such information or
methods they should be mindful of their own safety and the safety of others, including parties for whom they
have a professional responsibility.
With respect to any drug or pharmaceutical products identified, readers are advised to check the most current
information provided (i) on procedures featured or (ii) by the manufacturer of each product to be administered,
to verify the recommended dose or formula, the method and duration of administration, and contraindications.
It is the responsibility of practitioners, relying on their own experience and knowledge of their patients, to make
diagnoses, to determine dosages and the best treatment for each individual patient, and to take all appropriate
safety precautions.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any
liability for any injury and/or damage to persons or property as a matter of products liability, negligence or
otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the
material herein.
Printed in China
Commissioning Editor: Laurence Hunter
Development Editor: Lynn Watt
Project Manager: Vinod Kumar Iyyappan
Designer/Design Direction: Miles Hitchen
Illustration Manager: Jennifer Rose
Illustrator: Antbits Ltd
The
Publisher's
policy is to use
paper manufactured
from sustainable forests

Contents
Contributors vii
Series Editors' preface ix
Editors' preface xi
Evidence-based practice in surgery xiii
1 Liver function and failure 1
Stephen J. Wigmore, Benjamin M. Stutchfield and Stuart J. Forbes
2 Hepatic, biliary and pancreatic anatomy 17
Steven M. Strasberg
3 Staging and assessment of hepatobiliary malignancies 39
Steve M.M. de Castro, Otto M. van Delden, Dirk J. Gouma and
Olivier R.C. Busch
4 Benign liver lesions 59
Rowan W. Parks, O. James Garden and Jean-Francois Gigot
5 Primary malignant tumours of the liver 80
Chetana Lim and Olivier Farges
6 Colorectal liver metastases 109
Declan F.J. Dunne, Robert P. Jones, René Adam and Graeme J. Poston
7 Non-colorectal hepatic metastases 132
Zaheer Kanji, Lynn Mikula, Carol-Anne Moulton and Steven Gallinger
8 Portal hypertension 146
Geoffrey H. Haydon, John Isaac, John A.C. Buckels and Simon P. Olliff
9 The spleen 164
Chee-Chee H. Stucky and Richard T. Schlinkert
10 Gallstones 174
Leslie K. Nathanson
11 Benign biliary tract diseases 196
Benjamin N.J. Thomson and O. James Garden
12 Malignant lesions of the biliary tract 218
Shishir K. Maithel and William R. Jarnagin
v

Contents
13 Acute pancreatitis 244
Colin J. McKay, Euan J. Dickson and C. Ross Carter
14 Chronic pancreatitis 260
Alexandra M. Koenig, Kai Bachmann and Jakob R. Izbicki
15 Pancreatic adenocarcinoma 275
Michael E. Kelly and Kevin C. Conlon
16 Cystic and neuroendocrine tumours of the pancreas 289
Saxon Connor
17 Hepatobiliary and pancreatic trauma 304
Rowan W. Parks
Index 327
vi

Contributors
René Adam, MD, PhD
Professor of Surgery, Universite Paris-Sud;
Centre Hepato-Biliaire, Hôpital Paul Brousse,
University Paris-Sud, Paris, France
Kai Bachmann, MD
Department of General, Visceral and
Thoracic Surgery, University Medical Center,
Hamburg-Eppendorf, Germany
John A.C. Buckels, CBE, MD, FRCS
Professor of Hepatobiliary and Transplant Surgery
Liver Unit, University Hospital Birmingham NHS Trust
Queen Elizabeth Hospital, Birmingham, UK
Olivier R.C. Busch, MD, PhD
Gastrointestinal Surgeon, Department of Surgery,
Academic Medical Center, Amsterdam, The
Netherlands
C. Ross Carter, MBChB, FRCS, MD, FRCS(Gen)
Consultant Pancreaticobiliary Surgeon, West of
Scotland Pancreatic Unit, Glasgow Royal Infirmary,
Glasgow, UK
Steve M.M. de Castro, MD, PhD
Chief Surgery Resident, Department of Surgery,
Academic Medical Center, Amsterdam, The
Netherlands
Kevin C. Conlon, MA, MCh, MBA, FRCSI, FACS,
FRCS, FTCD
Chair of Surgery, Professorial Surgical Unit, University
of Dublin, Trinity College; St Vincent's University
Hospital, Dublin, Ireland
Saxon Connor, MBChB, FRACS
HPB Surgeon, General Surgery, Christchurch
Hospital, Christchurch, New Zealand
Otto M. van Delden, MD, PhD
Interventional Radiologist, Department of Radiology,
Academic Medical Center, Amsterdam, The
Netherlands
Euan J. Dickson, MBChB, MD, FRCS
Consultant Surgeon, West of Scotland Pancreatic
Unit, Glasgow Royal Infirmary, Glasgow, UK
Declan F.J. Dunne, MBChB(Hons), MRCS
Surgical Research Fellow, University of Liverpool;
Department of Hepatobiliary Surgery, Aintree
University Hospital, Liverpool, UK
Olivier Farges, MD, PhD
Professor of Surgery, Department of Hepato-biliary
and Pancreatic Surgery and Liver Transplantation,
Hôpital Beaujon, Université Paris 7, Paris, France
Stuart J. Forbes, FRCP(Ed), PhD
Professor of Transplantation and Regenerative Medicine,
MRC Centre for Regenerative Medicine, Edinburgh, UK,
Steven Gallinger, MD, MSc, FRCSC
Professor of Surgery, Division of General Surgery
Toronto General Hospital, University Health Network,
University of Toronto, Toronto, Canada
O. James Garden, BSc, MBChB, MD,
FRCS(Glas), FRCS(Ed), FRCP(Ed) FRACS(Hon),
FRCSC(Hon), FRSE
Regius Professor of Clinical Surgery, Clinical Surgery,
School of Clinical Sciences and Community Health,
The University of Edinburgh; Honorary Consultant
Surgeon, Royal Infirmary of Edinburgh, Edinburgh, UK
Jean-François Gigot, MD, PhD, FRCS
Professor of Surgery, Division of HBP Surgery,
Department of Abdominal Surgery and Transplantation,
Cliniques Universitaires Saint-Luc, Université
Catholique de Louvain (UCL), Brussels, Belgium
Dirk J. Gouma, MD, PhD
Professor of Surgery, Chair of the Department of
Surgery, Academic Medical Center, Amsterdam,
The Netherlands
Geoffrey H. Haydon, MBChB, MSc, MD, FRCP
Consultant Hepatologist, Liver Unit, Queen Elizabeth
Hospital, University Hospital Birmingham NHS Trust,
Birmingham, UK
John R. Isaac, MBBS, MMed(Surgery),
FRCS(Edin), FRCS(Glasg), FAMS
Hepato-Pancreatico-Biliary and Liver Transplant
Surgeon, Liver Unit, Queen Elizabeth Hospital, University
Hospital Birmingham NHS Trust, Birmingham, UK
vii

Contributors
Jakob R. Izbicki, MD, FACS
Department of General, Visceral and
Thoracic Surgery, University Medical Center,
Hamburg-Eppendorf, Germany
William R. Jarnagin, MD, FACS
Enid A. Haupt Chair in Surgery, Professor of Surgery;
Chief, HPB Service, Department of Surgery, Memorial
Sloan-Kettering Cancer Center, New York, NY, USA
Robert P. Jones, BSc (Hons), MBChB
Surgical Research Fellow, University of Liverpool;
Northwestern Hepatobiliary Unit, Aintree University
Hospital, Liverpool, UK
Zaheer S. Kanji, MD, BSc, BMedSci
Research Fellow, Samuel Lunenfeld Research
Institute of Mount Sinai Hospital, University of
Toronto, Toronto, Canada; Resident Physician,
Division of General Surgery, University of British
Columbia, Vancouver, Canada
Michael E. Kelly, BA, MBBCh, BAO, MRCS
Adelaide & Meath Hospital, Tallaght, Dublin,
Ireland
Alexandra M. Koenig, MD
Department of General, Visceral and Thoracic
Surgery, University Medical Center, HamburgEppendorf, Germany
Chetana Lim, MD
Department of Hepato-biliary and Pancreatic
Surgery and Liver Transplantation, Hôpital Beaujon,
Université Paris 7, Paris, France
Leslie K. Nathanson, MBChB, FRACS
Consultant Surgeon, Royal Brisbane and Women's
Hospital, Herston, Australia
Simon P. Olliff, MRCP, FRCR
Consultant Radiologist, Department of Radiology,
Queen Elizabeth Hospital, Birmingham, UK
Rowan W. Parks, MBBCh, BAO, MD, FRCSI,
FRCS(Ed)
Professor of Surgical Sciences, Clinical Surgery,
School of Clinical Sciences and Community Health,
The University of Edinburgh; Honorary Consultant
Surgeon, Royal Infirmary of Edinburgh,
Edinburgh, UK
Graeme J. Poston, MBBS, MS, FRCS
Professor of Surgery, University of Liverpool;
Northwestern Hepatobiliary Unit, Aintree University
Hospital, Liverpool, UK
Richard T. Schlinkert, MD, FACS
Professor of Surgery, Mayo Clinic College of
Medicine; Consultant Surgeon, Department of
Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA
Steven M. Strasberg, MD, FRCS(C), FACS,
FRCS(Ed)
Pruett Professor of Surgery, Section of HepatoPancreato-Biliary Surgery, Washington University in
Saint Louis, St Louis, MO, USA
Chee-Chee H. Stucky, MD
Surgical Resident, General Surgery, Mayo Clinic
Arizona, Phoenix, AZ, USA
Lynn Mikula, MD, MSc
Consulting General Surgeon, Peterborough, Ontario,
Canada
Carol-Anne Moulton, MBBS, MEd, PhD, FRACS
Associate Professor of Surgery, Division of General
Surgery, Toronto General Hospital, University Health
Network, University of Toronto, Toronto, Canada
Colin J. McKay, MBChB, MD, FRCS
Consultant Surgeon, West of Scotland Pancreatic
Unit, Glasgow Royal Infirmary Glasgow, UK
Shishir K. Maithel, MD, FACS
Assistant Professor of Surgery, Division of Surgical
Oncology, Department of Surgery, Emory University
School of Medicine, Atlanta, GA, USA
viii
Benjamin M. Stutchfield, BSc, MBChB, MSc,
MRCS(Ed)
Clinical Research Fellow, MRC Centre for
Regenerative Medicine, The University of Edinburgh,
Edinburgh, UK
Benjamin N.J. Thomson, MBBS, DMedSc, FRACS
Head of Specialist General Surgery, Royal Melbourne
Hospital, Parkville, Victoria, Australia
Stephen J. Wigmore, BSc(Hons), MBBS, MD,
FRCSEd, FRCS(Gen Surg)
Professor of Transplantation Surgery, Clinical Surgery,
School of Clinical Sciences and Community Health,
The University of Edinburgh; Clinical Director General
Surgery and Transplantation, Royal Infirmary of
Edinburgh, Edinburgh, UK

Series Editors' preface
It is now some 17 years since the first edition of the
Companion to Specialist Surgical Practice series was
published. We set ourselves the task of meeting the
educational needs of surgeons in the later years of
specialist surgical training, as well as consultant
surgeons in independent practice who wished for
contemporary, evidence-based information on the
subspecialist areas relevant to their general surgical
practice. The series was never intended to replace the
large reference surgical textbooks which, although
valuable in their own way, struggle to keep pace with
changing surgical practice. This Fifth Edition has also
had to take due account of the increasing specialisation in ‘general’ surgery. The rise of minimal access
surgery and therapy, and the desire of some subspecialties such as breast and vascular surgery to separate away from ‘general surgery’, may have proved
challenging in some countries, but has also served
to emphasise the importance of all surgeons being
aware of current developments in their surgical field.
As in previous editions, there has been increasing emphasis on evidence-based practice and contributors
have endeavoured to provide key recommendations
within each chapter. The e-Book versions of the textbook have also allowed the technophile improved
access to key data and content within each chapter.
We remain indebted to the volume editors and
all the contributors of this Fifth Edition. We have
endeavoured where possible to bring in new blood
to freshen content. We are impressed by the enthusiasm, commitment and hard work that our contributors and editorial team have shown and this
has ensured a short turnover between editions while
maintaining as accurate and up-to-date content
as is possible. We remain grateful for the support
and encouragement of Laurence Hunter and Lynn
Watt at Elsevier Ltd. We trust that our original vision of delivering an up-to-date affordable text has
been met and that readers, whether in training or
independent practice, will find this Fifth Edition an
invaluable resource.
O. James Garden BSc, MBChB, MD, FRCS(Glas),
FRCS(Ed), FRCP(Ed), FRACS(Hon), FRCSC(Hon),
FRSE
Regius Professor of Clinical Surgery, Clinical
Surgery School of Clinical Sciences, The University
of Edinburgh and Honorary Consultant Surgeon,
Royal Infirmary of Edinburgh
Simon Paterson-Brown MBBS, MPhil, MS,
FRCS(Ed), FRCS(Engl), FCS(HK)
Honorary Senior Lecturer, Clinical Surgery School
of Clinical Sciences, The University of Edinburgh
and Consultant General and Upper Gastrointestinal
Surgeon, Royal Infirmary of Edinburgh
ix

Editors' preface
This Fifth Edition of Hepatobiliary and Pancreatic
Surgery continues to build on the strong founda-
tions of previous contributors since the First Edition
appeared in 1997. My colleague, Professor Rowan
Parks has joined me as Editor of this volume in an
effort to bring fresh thought regarding content and
format. Each edition delivers refinement and updates to existing chapters, which have been updated
extensively. We have endeavoured to secure leading
international contributors who will keep the reader
at the forefront of those rapidly developing areas of
HPB surgery.
The content is as comprehensive as any previous
edition although we have not attempted to duplicate
some areas of the speciality which are addressed
in the Endocrine or Transplantation Volumes. All
chapters have been brought up to date with new
evidence base and references. We have endeavoured
to maintain a uniform style and we are grateful to
our contributors for allowing us to make various
amendments of content to achieve this.
Acknowledgements
We are grateful to colleagues at Elsevier for trying to
keep us on schedule and for addressing issues of style,
formatting and layout. We would wish to acknowledge the tremendous support and tolerance shown by
our families in allowing us to deliver this volume and
take us to 20 years of the Companion Series.
O. James Garden
Rowan W. Parks
Edinburgh
xi
Соседние файлы в папке Библиотека им академика М.И. Перельмана
